FibroGen Inc
NASDAQ:FGEN
FibroGen Inc
Cash from Financing Activities
FibroGen Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
FibroGen Inc
NASDAQ:FGEN
|
Cash from Financing Activities
$122.7m
|
CAGR 3-Years
110%
|
CAGR 5-Years
55%
|
CAGR 10-Years
68%
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Financing Activities
-$17.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-17%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Financing Activities
-$5.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Financing Activities
$21B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
23%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Financing Activities
-$562.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Financing Activities
-$1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-88%
|
CAGR 10-Years
N/A
|
See Also
What is FibroGen Inc's Cash from Financing Activities?
Cash from Financing Activities
122.7m
USD
Based on the financial report for Dec 31, 2023, FibroGen Inc's Cash from Financing Activities amounts to 122.7m USD.
What is FibroGen Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
68%
Over the last year, the Cash from Financing Activities growth was 162%. The average annual Cash from Financing Activities growth rates for FibroGen Inc have been 110% over the past three years , 55% over the past five years , and 68% over the past ten years .